Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 10, 2015, Pages 12621-12633

  Lan, Jiaojiao ^a   Huang, Bing ^a   Liu, Ruixue ^a   Ju, Xinxin ^a   Zhou, Yang ^a   Jiang, Jinfang ^a   Liang, Weihua ^a   Shen, Yaoyuan ^a   Li, Feng ^a   Pang, Lijuan ^a  

^a SHIHEZI UNIVERSITY   (China)

Author keywords

Cancer stem cells; Immunohistochemistry; Pathogenesis; Vascular tumor

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 1; BETA1 INTEGRIN; CD133 ANTIGEN; CD44 PROTEIN, HUMAN; GLYCOPROTEIN; HERMES ANTIGEN; ISOENZYME; LEUKOCYTE ANTIGEN; NES PROTEIN, HUMAN; NESTIN; PEPTIDE; PROM1 PROTEIN, HUMAN; RETINAL DEHYDROGENASE; TRANSCRIPTOME; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; BIOSYNTHESIS; CANCER STEM CELL; CHILD; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; VASCULAR TUMOR;

AC133 ANTIGEN; ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD29; ANTIGENS, CD44; BIOMARKERS, TUMOR; CHILD; CHILD, PRESCHOOL; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; NESTIN; PEPTIDES; RETINAL DEHYDROGENASE; TRANSCRIPTOME; VASCULAR NEOPLASMS;

EID: 85013187887     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Katenkamp K and Katenkamp D. Soft tissue tumors: new perspectives on classification and diagnosis. Dtsch Arztebl Int 2009; 106: 632-636.
2. Ramon F, Degryse H and De Schepper A. Vascular soft tissue tumors: medical imaging. J Belge Radiol 1992; 75: 303-310.
3. Greenberger S and BischoffJ. Pathogenesis of infantile haemangioma. Br J Dermatol 2013; 169: 12-19.
4. Khan ZA, Melero-Martin JM, Wu X, Paruchuri S, Boscolo E, Mulliken JB and BischoffJ. Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood 2006; 108: 915-921.
5. Qiu M, Qi X, Dai Y, Wang S, Quan Z, Liu Y and Ou J. Infantile haemangioma: a complicated disease. Front Biosci (Landmark Ed) 2015; 20: 1004-1016.
6. Kakiuchi-Kiyota S, Crabbs TA, Arnold LL, Pennington KL, Cook JC, Malarkey DE and Cohen SM. Evaluation of expression profiles of hematopoietic stem cell, endothelial cell, and myeloid cell antigens in spontaneous and chemically induced hemangiosarcomas and hemangiomas in mice. Toxicol Pathol 2013; 41: 709-721.
7. Koch M, Nielsen GP and Yoon SS. Malignant tumors of blood vessels: angiosarcomas, hemangioendotheliomas, and hemangioperictyomas. J Surg Oncol 2008; 97: 321-329.
8. Chokoeva A and Tchernev G. [Malignant vascular tumors of the vulva]. Akush Ginekol (Sofiia) 2015; 54: 48-52.
9. Ma JK, Barr J and Vijayakumar S. A multidisciplinary approach to the management of atypical osseous epithelioid hemangioendothelioma. Case Rep Oncol Med 2014; 2014: 917425.
10. Roy S and Parwani AV. Primary renal epithelioid hemangioendothelioma. Case Rep Pathol 2012; 2012: 802515.
11. Liu L, Kakiuchi-Kiyota S, Arnold LL, Johansson SL, Wert D and Cohen SM. Pathogenesis of human hemangiosarcomas and hemangiomas. Hum Pathol 2013; 44: 2302-2311.
12. Yonemori K, Tsuta K, Ando M, Hirakawa A, Hatanaka Y, Matsuno Y, Chuman H, Yamazaki N, Fujiwara Y and Hasegawa T. Contrasting prognostic implications of platelet-derived growth factor receptor-beta and vascular endothelial growth factor receptor-2 in patients with angiosarcoma. Ann Surg Oncol 2011; 18: 2841-2850.
13. Gurzu S, Ciortea D, Munteanu T, Kezdi-Zaharia I and Jung I. Mesenchymal-to-endothelial transition in Kaposi sarcoma: a histogenetic hypothesis based on a case series and literature review. PLoS One 2013; 8: e71530.
14. Kandemir NO, Gun BD, Bahadir B, Yurdakan G, Ozdemir N, Karadayi N and Ozdamar SO. c-Kit (CD117) expression in classic Kaposi's sarcoma. Clin Exp Dermatol 2010; 35: 525-530.
15. Liu A, Feng B, Gu W, Cheng X, Tong T, Zhang H and Hu Y. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics. Int J Oncol 2013; 42: 1399-1407.
16. Boman BM and Wicha MS. Cancer stem cells: a step toward the cure. J Clin Oncol 2008; 26: 2795-2799.
17. Feng JQ, Xu ZY, Shi LJ, Wu L, Liu W and Zhou ZT. Expression of cancer stem cell markers ALDH1 and Bmi1 in oral erythroplakia and the risk of oral cancer. J Oral Pathol Med 2013; 42: 148-153.
18. Liu J, Ma L, Xu J, Liu C, Zhang J, Chen R and Zhou Y. Co-expression of CD44 and ABCG2 in spheroid body-forming cells of gastric cancer cell line MKN45. Hepatogastroenterology 2013; 60: 975-980.
19. Bonnet D and Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-737.
20. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005; 65: 5506-5511.
21. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C and De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-115.
22. Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S, Xia L, Zhou N, Riddle M, Schroeder TM, Westendorf JJ, McIvor RS, Hogendoorn PC, Szuhai K, Oseth L, Hirsch B, Yant SR, Kay MA, Peister A, Prockop DJ, Fibbe WE and Blazar BR. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007; 25: 371-379.
23. Suva ML, Riggi N, Stehle JC, Baumer K, Tercier S, Joseph JM, Suva D, Clement V, Provero P, Cironi L, Osterheld MC, Guillou L and Stamenkovic I. Identification of cancer stem cells in Ewing's sarcoma. Cancer Res 2009; 69: 1776-1781.
24. Zhou F, Mu YD, Liang J, Liu ZX, Chen HS and Zhang JF. Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma. Oncol Lett 2014; 7: 507-512.
25. Calloni R, Cordero EA, Henriques JA and Bonatto D. Reviewing and updating the major molecular markers for stem cells. Stem Cells Dev 2013; 22: 1455-1476.
26. Vassilopoulos A, Chisholm C, Lahusen T, Zheng H and Deng CX. A critical role of CD29 and CD49f in mediating metastasis for cancer-initiating cells isolated from a Brca1-associated mouse model of breast cancer. Oncogene 2014; 33: 5477-5482.
27. Nishikawa S, Konno M, Hamabe A, Hasegawa S, Kano Y, Fukusumi T, Satoh T, Takiguchi S, Mori M, Doki Y and Ishii H. Surgically resected human tumors reveal the biological significance of the gastric cancer stem cell markers CD44 and CD26. Oncol Lett 2015; 9: 2361-2367.
28. Yan Y, Zuo X and Wei D. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target. Stem Cells Transl Med 2015; 4: 1033-43.
29. Cherciu I, Barbalan A, Pirici D, Margaritescu C and Saftoiu A. Stem cells, colorectal cancer and cancer stem cell markers correlations. Curr Health Sci J 2014; 40: 153-161.
30. Arbiser JL, Bonner MY and Berrios RL. Hemangiomas, angiosarcomas, and vascular malformations represent the signaling abnormalities of pathogenic angiogenesis. Curr Mol Med 2009; 9: 929-934.
31. Jordan CT, Guzman ML and Noble M. Cancer stem cells. N Engl J Med 2006; 355: 1253-1261.
32. Gibbs CP, Kukekov VG, Reith JD, Tchigrinova O, Suslov ON, Scott EW, Ghivizzani SC, Ignatova TN and Steindler DA. Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia 2005; 7: 967-976.
33. Yin S, Li J, Hu C, Chen X, Yao M, Yan M, Jiang G, Ge C, Xie H, Wan D, Yang S, Zheng S and Gu J. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 2007; 120: 1444-1450.
34. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J and Buck DW. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90: 5002-5012.
35. P M, S H, R M, M G and W SK. Adult mesenchymal stem cells and cell surface characterization-a systematic review of the literature. Open Orthop J 2011; 5: 253-260.
36. Khan ZA, Boscolo E, Picard A, Psutka S, Melero-Martin JM, Bartch TC, Mulliken JB and BischoffJ. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 2008; 118: 2592-2599.
37. Taddeo A, Presicce P, Brambilla L, Bellinvia M, Villa ML and Della Bella S. Circulating endothelial progenitor cells are increased in patients with classic Kaposi's sarcoma. J Invest Dermatol 2008; 128: 2125-2128.
38. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA and Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-958.
39. Beaudry P, Hida Y, Udagawa T, Alwayn IP, Greene AK, Arsenault D, Folkman J, Heymach JV, Ryeom S and Puder M. Endothelial progenitor cells contribute to accelerated liver regeneration. J Pediatr Surg 2007; 42: 1190-1198.
40. Urbich C and Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004; 95: 343-353.
41. Yuan SM, Chen RL, Shen WM, Chen HN and Zhou XJ. Mesenchymal stem cells in infantile hemangioma reside in the perivascular region. Pediatr Dev Pathol 2012; 15: 5-12.
42. Itinteang T, Davis PF and Tan ST. Infantile hemangiomas exhibit neural crest and pericyte markers. Ann Plast Surg 2015; 74: 383.
43. Mai HM, Zheng JW, Wang YA, Yang XJ, Zhou Q, Qin ZP and Li KL. CD133 selected stem cells from proliferating infantile hemangioma and establishment of an in vivo mice model of hemangioma. Chin Med J (Engl) 2013; 126: 88-94.
44. Yu Y, Fuhr J, Boye E, Gyorffy S, Soker S, Atala A, Mulliken JB and BischoffJ. Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells 2006; 24: 1605-1612.
45. Itinteang T, Vishvanath A, Day DJ and Tan ST. Mesenchymal stem cells in infantile haemangioma. J Clin Pathol 2011; 64: 232-236.
46. Rani SB, Mahadevan A, Anilkumar SR, Raju TR and Shankar SK. Expression of nestin-a stem cell associated intermediate filament in human CNS tumours. Indian J Med Res 2006; 124: 269-280.
47. Tsujimura T, Makiishi-Shimobayashi C, Lundkvist J, Lendahl U, Nakasho K, Sugihara A, Iwasaki T, Mano M, Yamada N, Yamashita K, Toyosaka A and Terada N. Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal. Am J Pathol 2001; 158: 817-823.
48. Yang XH, Wu QL, Yu XB, Xu CX, Ma BF, Zhang XM, Li SN, Lahn BT and Xiang AP. Nestin expression in different tumours and its relevance to malignant grade. J Clin Pathol 2008; 61: 467-473.
49. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS and Dontu G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-567.
50. Wu J, Mu Q, Thiviyanathan V, Annapragada A and Vigneswaran N. Cancer stem cells are enriched in Fanconi anemia head and neck squamous cell carcinomas. Int J Oncol 2014; 45: 2365-2372.
51. Su Y, Qiu Q, Zhang X, Jiang Z, Leng Q, Liu Z, Stass SA and Jiang F. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Cancer Epidemiol Biomarkers Prev 2010; 19: 327-337.
52. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, Fields JZ, Wicha MS and Boman BM. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 2009; 69: 3382-3389.